We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
» FDA Offers Sanitation Advice to Drug Compounders
FDA Offers Sanitation Advice to Drug Compounders
December 11, 2020
Pharmaceuticals
Regulatory Affairs
The FDA published final guidance designed to help drug compounders recognize, prevent and respond to insanitary conditions at their facilities.
To View This Article:
Login
Email
{:reset=>{:title=>"Reset Password", :reminder=>"We have sent an email with instructions for resetting your password.", :token_expired=>"The supplied reset token has expired.", :password_mismatch=>"The submitted passwords do not match. Please try again.", :insufficient=>"Please enter your new password below. Passwords should be at least 8 characters in length and must include at least one capital letter and one number.", :success=>"Password successfully saved.", :failure=>"Unable to save your new password. Please contact the site administrator."}}
Register
Remember Me
Forgot your password?
Subscribe To Drug GMP Report
Buy This Article Now
Add this article to your cart for $40.00
Upcoming Events
08
Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
15
Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20
Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21
Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
22
Sep
FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers
11
Oct
1st Annual Quality Management vSummit
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
FDA Issues Update on Becton Dickinson’s Recall
FDA Grants Accelerated Approval to Enhertu for HER2-Mutant NSCLC
Thermo Fisher Scientific Gets FDA Premarket Approval for Companion Diagnostic
MHRA Grants Conditional Authorization to Moderna’s Bivalent COVID-19 Booster Vaccine
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
